Graham Capital Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$671K Sell
8,032
-6,524
-45% -$535K 0.02% 547
2025
Q4
$1.33M Buy
14,556
+3,638
+33% +$348K 0.03% 324
2025
Q3
$1.03M Buy
10,918
+8,026
+278% +$755K 0.02% 376
2025
Q2
$303K Buy
+2,892
New +$274K ﹤0.01% 992
2024
Q4
Sell
-4,750
Closed -$389K 1338
2024
Q3
$389K Buy
+4,750
New +$366K 0.01% 708
2024
Q2
Sell
-17,668
Closed -$1.44M 1176
2024
Q1
$1.44M Sell
17,668
-43,934
-71% -$3.43M 0.03% 317
2023
Q4
$4.08M Buy
+61,602
New +$4.27M 0.09% 128

Other funds holding HQY

Graham Capital Management's HQY Position: Q1 2026 in Review

Graham Capital Management reduced its HealthEquity (HQY) stake by 45% in Q1 2026, selling an estimated $535K and leaving 8,032 shares worth $671K. The position accounts for 0.02% of the portfolio, ranked #547.

Graham Capital Management first reported a position in HQY in Q4 2023 and has held it in 7 quarters since. The position peaked at $4.08M in Q4 2023. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • Graham Capital Management held 8,032 shares of HealthEquity worth $671K as of Q1 2026.
  • Graham Capital Management sold 6,524 HealthEquity shares in Q1 2026, an estimated $535K.
  • HealthEquity made up 0.02% of Graham Capital Management's portfolio in Q1 2026, its #547 holding.
  • Graham Capital Management first reported a position in HealthEquity in Q4 2023 and has held it in 7 quarters since.
  • Graham Capital Management's HealthEquity position peaked at $4.08M in Q4 2023.
  • 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.